Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 9Breast 5CNS 3Gynecologic 2Other hematologic neoplasm 1Genitourinary 1Dermatologic 1

Conditions

Ovarian Neoplasms 359Endometrial Neoplasms 207Uterine Cervical Neoplasms 187Breast Neoplasms 109Fallopian Tube Neoplasms 96Colorectal Neoplasms 83Carcinoma, Non-Small-Cell Lung 76Neoplasms 65Pancreatic Neoplasms 59Stomach Neoplasms 55Neoplasm Metastasis 51Prostatic Neoplasms 50Lung Neoplasms 46Melanoma 43Carcinoma, Ovarian Epithelial 41Triple Negative Breast Neoplasms 38Squamous Cell Carcinoma of Head and Neck 36Esophageal Neoplasms 35Carcinoma, Renal Cell 35Colonic Neoplasms 31Urinary Bladder Neoplasms 30Peritoneal Neoplasms 29Head and Neck Neoplasms 28Vulvar Neoplasms 26Uterine Neoplasms 26Carcinoma, Hepatocellular 26Carcinoma, Transitional Cell 24Small Cell Lung Carcinoma 23Sarcoma 20Rectal Neoplasms 19

Interventions

Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Cognitive Dysfunction × Gynecologic × 90 days × Clear all
NCT04520139 2026-04-29

Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT

University of California, Irvine

Phase 1/2 Not yet recruiting
102 enrolled
Gynecologic

Chemotherapy-Related Cognitive Impairment, Ovarian Neoplasms, Cognitive Dysfunction

NCT06662435 2026-03-23

GYNCOG

Northwestern University

Phase NA Completed
60 enrolled
Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡